December 17, 2024 - 01:21

Chrystia Freeland has announced her resignation as Canada’s Finance Minister, a decision that comes in the wake of escalating tensions between Canada and the United States under the renewed leadership of Donald Trump. In her resignation letter, Freeland cited the Canadian government's response to Trump’s tariff threats as a significant factor in her decision to step down.
Freeland, who has been a prominent figure in Canadian politics, played a crucial role in navigating trade relations with the U.S., especially during the renegotiation of NAFTA. Her departure raises questions about the future direction of Canada’s economic policies and the government’s approach to dealing with potential trade conflicts.
Prime Minister Justin Trudeau now faces the challenge of finding a suitable replacement who can effectively manage the delicate relationship with the U.S. and address the economic concerns that have arisen from the ongoing trade disputes. Freeland’s resignation marks a pivotal moment in Canadian politics as the country braces for the implications of a new Trump term.
November 11, 2026 - 03:35
Resideo Reports Third Quarter 2026 Financial Performance and Outlook UpdateResideo Technologies, Inc. has shared its financial results for the third quarter of 2026, which concluded on October 3. The company, known for its innovative control and sensing solutions in the...
November 10, 2026 - 13:34
Hong Kong's Financial Transformation: China Aims for Global InfluenceA recent report explores how Beijing is reshaping Hong Kong into a key player in the global financial landscape. The analysis, conducted by ASPI`s Center for China Analysis and Enodo Economics,...
November 10, 2026 - 09:52
BitGo Holdings Reports Significant Revenue Decline in Q3BitGo Holdings, known by the ticker BTGO, has revealed a troubling 50.9% drop in year-over-year revenue for the third quarter. The decline is largely attributed to a slowdown in digital asset...
November 9, 2026 - 21:06
New Drug Application Submitted for Azetukalner in Focal SeizuresIn September 2026, a New Drug Application for azetukalner, a treatment for focal seizures, was submitted to the U.S. Food and Drug Administration. This marks a significant step forward in expanding...